source
- Recon: Sino, Boehringer ink cancer drug deal worth $7B; CVS to split pharmacy business from insuranceWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 4d ago↗ source
- CVS Health to split into two publicly traded companies amid regulatory scrutiny of its pharmacy‑insurer integrationCVS Health announced it will separate into two independent, publicly traded companies. The move undoes years of acquisitions that combined a pharmacy chain, a pharmacy‑benefit manager and an insura…
- Bernie Sanders poised to steer FDA user fee renewal, could push for reforms